REFERENCES
- Singh S, Darroch JE. Adding it up: costs and benefits of contraceptive services – Estimates for 2012. New York: Guttmacher Institute; UNFPA; 2012. Accessed 15 July 2012 from: http://www.guttmacher.org/pubs/AIU-2012-estimates.pdf
- Reynolds HW, Janowitz B, Homan R, Johnson L. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis 2006;33:350–6.
- WHO, UNAIDS, UNICEF. Global HIV/AIDS Response – Epidemic update and health sector progress towards Universal Access – Progress report 2011. Geneva: World Health Organization 2011.
- United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2008 revision. New York: United Nations 2009.
- Cleland JG, Ndugwa RP, Zulu EM. Family planning in sub-Saharan Africa: Progress or stagnation?Bull World Health Organ 2011;89:137–43.
- Darroch JE, Sedgh G, Ball H. Contraceptive technologies: Responding to women's needs. New York: Guttmacher Institute 2011.
- United Nations Department of Economic and Social Affairs, Population Division. Wall chart. New York: United Nations 2011. Accessed 15 July 2012 from: http://www.un.org/esa/population/publications/contraceptive2011/wallchart_front.pdf
- UNAIDS. AIDS Epidemic update 2009. Geneva: UNAIDS 2010.
- Plummer FA, Simonsen JN, Cameron DW, . Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163: 233–9.
- Heffron R, Donnell D, Rees H, . Use of hormonal contraceptives and risk of HIV-1 transmission: A prospective cohort study. Lancet Infect Dis 2012;12:19–26.
- Contraceptive used in Africa may double risk of H.I.V. The New York Times 3 October 2011.
- Wadman M. Contraceptive risk of HIV long suspected. Nature (News online 7 October 2011). Accessed 15 July 2012 from: http://www.nature.com/news/2011/111007/full/news.2011.582.html">
- Population Council. What have we really learned about HIV and hormonal contraceptives this week? Accessed 15 July 2012 from: http://www.popcouncil.org/mediacenter/newsreleases/2011_StatementHIVHormonalContr.asp
- USAID. USAID response to new findings on hormonal contraception and HIV acquisition in uninfected women and HIV transmission from infected women to male partners. USAID, 2011 Accessed 15 July 2012 from: http://www.advancefamilyplanning.org/system/files/Updated%20USAID%20Heffron%20response%2010-7-11_0.pdf
- Family Health International. FHI 360 Statement on the Heffron et al study and hormonal contraceptives and HIV risk. Accessed 15 July from: http://www.fhi360.org/en/News/res_HormonalContraceptivesHIVRisk.htm
- Morrison CS, Turner AN, Jones LB. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009;23:263–84.
- WHO. Hormonal contraception and HIV. Technical statement. Geneva: World Health Organization 2012.
- Stephenson JM. Systematic review of hormonal contraception and risk of HIV transmission: When to resist meta-analysis. AIDS 1998;12:545–53.
- Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: A meta-analysis. J Acquir Immune Defic Syndr 1999;21:51–8.
- Lavreys L, Baeten JM, Martin HL, Jr., . Hormonal contraception and risk of HIV-1 acquisition: Results of a 10-year prospective study. AIDS 2004;18:695–7.
- Baeten JM, Benki S, Chohan V, . Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007;21:1771–7.
- Kiddugavu M, Makumbi F, Wawer MJ, . Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003;17: 233–40.
- Morrison CS, Richardson BA, Mmiro F, . Hormonal contraception and the risk of HIV acquisition. AIDS 2007;21:85–95.
- Kumwenda NI, Kumwenda J, Kafulafula G, . HIV-1 incidence among women of reproductive age in Malawi. Int J STD AIDS 2008;19:339–41.
- Feldblum PJ, Lie CC, Weaver MA, . Baseline factors associated with incident HIV and STI in four microbicide trials. Sex Transm Dis 2010;37:594–601.
- Reid SE, Dai JY, Wang J, . Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: Relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr 2010;53:606–13.
- Morrison CS, Skoler-Karpoff S, Kwok C, . Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS 2012;26:497–504.
- Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS 2012;26:375–80.
- Watson-Jones D, Baisley K, Weiss HA, . Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS 2009; 23:415–22.
- Mavedzenge SN, Weiss HA, Montgomery ET, . Determinants of differential HIV incidence among women in three southern African locations. J Acquir Immune Defic Syndr 2011;58:89–99.
- Glynn JR, Biraro S, Weiss HA. Herpes simplex virus type 2: A key role in HIV incidence. AIDS 2009; 23:1595–8.
- Gray RH. Use of hormonal contraceptives and risk of HIV-1 transmission. Lancet Infect Dis 2012;12:507.
- Hubacher D. Use of hormonal contraceptives and risk of HIV-1 transmission. Lancet Infect Dis 2012;12:508.
- Heffron R, Rees H, Mugo N, Baeten JM. Use of hormonal contraceptives and risk of HIV-1 transmission – Authors’ reply. Lancet Infect Dis 2012;12:510–1.
- Marx PA, Spira AI, Gettie A, . Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996;2:1084–9.
- Martin HL, Richardson BA, Nyange PM, . Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863–8.
- Miller L, Patton DL, Meier A, . Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000;96:431–9.
- Hladik F, McElrath MJ. Setting the stage: Host invasion by HIV. Nat Rev Immunol 2008;8:447–57.
- Ngure K, Heffron R, Mugo NR, . Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships. AIDS 2012;26: 513–8.
- World Health Organization. Review of priorities in research on hormonal contraception and IUDs and HIV infection. Geneva: WHO 2010.
- World Health Organization. Medical eligibility criteria for contraceptive use, 4th edn. WHO: Geneva 2010.
- Steen R, Shapiro K. Intrauterine contraceptive devices and risk of pelvic inflammatory disease: Standard of care in high STI prevalence settings. Reprod Health Matters 2004;12:136–43.
- Sutherland EG, Alaii J, Tsui S, . Contraceptive needs of female sex workers in Kenya – A cross- sectional study. Eur J Contracept Reprod Health Care 2011;16:173–82.
- World Health Organization, International Planned Parenthood Federation, Family Health International. Hormonal contraception and HIV: science and policy. Africa Regional Meeting, Nairobi, 19–21 September 2005. Statement (final). Accessed 20 August 2012 from: http://www.urbanreproductivehealth.org/publications/hormonal-contraception-and-hiv-science-and-policy-africa-regional-meeting-nairobi-19–21
- Berer M. Dual protection: Making sex safer for women. In: Ravindran TKS, Berer M, Cottingham J, eds. Beyond acceptability: Users’ perspectives on contraception. London: Reprod Health Matters for World Health Organization 1997:109–21.
- Reynolds HW, Luseno WK, Speizer IS. The measurement of condom use in four countries in East and southern Africa. AIDS Behav 2012;16:1044–53.
- The UK Government is working with the Bill & Melinda Gates Foundation and partners to host a Family Planning summit in London in July 2012. Accessed 15 July 2012 from: http://www.dfid.gov.uk/News/Latest-news/2012/Family-planning-UK-to-host-summit-with-Gates-Foundation/
- Morrison CS, Nanda K. Hormonal contraception and HIV: An unanswered question. Lancet Infect Dis 2012; 12:2–3.